Search Results - "Hematology (Luxembourg)"

Risk factors for hospitalizations and readmissions among individuals with sickle cell disease: results of a U.S. survey study by Cronin, Robert M., Hankins, Jane S., Byrd, Jeannie, Pernell, Brandi M., Kassim, Adetola, Adams-Graves, Patricia, Thompson, Alexis, Kalinyak, Karen, DeBaun, Michael, Treadwell, Marsha

“…Objective: Hospital admissions are significant events in the care of individuals with sickle cell disease (SCD) due to associated costs and potential for…”
Get full text

Minimal residual disease level predicts outcome in adults with Ph-negative B-precursor acute lymphoblastic leukemia by Gökbuget, Nicola, Dombret, Hervé, Giebel, Sebastian, Bruggemann, Monika, Doubek, Michael, Foà, Robin, Hoelzer, Dieter, Kim, Christopher, Martinelli, Giovanni, Parovichnikova, Elena, Rambaldi, Alessandro, Ribera, Josep-Maria, Schoonen, Marieke, Stieglmaier, Julia M., Zugmaier, Gerhard, Bassan, Renato

“…Objectives: Detectable minimal residual disease (MRD) after therapy for acute lymphoblastic leukemia (ALL) is the strongest predictor of hematologic relapse…”
Get full text

Efficacy and safety of venetoclax-based combination therapy for previously untreated acute myeloid leukemia: a meta-analysis by He, Hongbo, Wen, Xiaojia, Zheng, Huyong

“…To explore the efficacy and safety of venetoclax-based combination therapy for older patients with newly diagnosed acute myeloid leukemia (AML). We performed a…”
Get full text

Understanding thrombosis: the critical role of oxidative stress by Li, Peiming, Ma, Xueru, Huang, Guofei

“…Thrombosis, a leading contributor to global health burden, is a complex process involving the interplay of various cell types, including vascular endothelial…”
Get full text

Procalcitonin level threshold and antibiotic use in patients receiving chimeric antigen receptor T-cell therapy by Ramesh, Murari, Yartsev, Alex

“…Patients undergoing chimeric antigen receptor (CAR) T-cell therapy are vulnerable to infection and sepsis. Treatment course is frequently complicated by…”
Get full text

Construction and validation of an 18F-FDG-PET/CT-based prognostic model to predict progression-free survival in newly diagnosed multiple myeloma patients by Dong, Xiaoqing, Wang, Ruoyi, Ying, Xiuhua, Xu, Jiaxuan, Yan, Jie, Xu, Peipei, Peng, Yue, Chen, Bing

“…OBJECTIVETo investigate the relationship between 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) related parameters…”
Get full text

Nonlinearity association of blood cobalt with the risk of anemia among middle-aged and older adults: National Health and Nutrition Examination Survey by Wang, Xia, Zhang, Ye, Liu, Xuntao, Zhou, Sutao, Cheng, Peng, Zhang, Bizhu, Zhang, Bin

“…Objective The use of cobalt alloys in medical implants poses a high risk of cobalt exposure, yet there is a lack of evidence regarding the association between…”
Get full text

Global research trends in traditional Chinese medicine therapy for acute leukemia: a comprehensive visualization and bibliometric analysis by Zhang, Wenwen, Zhang, Kaili, Feng, Yuqing, Zhang, Gaofeng

“…The application of traditional Chinese medicine (TCM) therapy to acute leukemia has been intensively investigated. However, the bibliometric analysis in this…”
Get full text

The value of Mentzer index in the diagnosis of children thalassemia minor by Wu, Tao, Ren, Zhenmin, Feng, Yandie, Li, Defa, Chen, Yunsheng

“…Objective: To explore the effect of the Mentzer Index (MI) in screening for children thalassemia (TT) minor.Methods: We determined the MI cutoff value of…”
Get full text

Treatment of minimal residual disease in myeloid malignancies after allo-HSCT with venetoclax-based regimens in patients ineligible for or failed in the immunotherapy by Yu, Wen-Jing, Kong, Jun, Zheng, Feng-Mei, Mo, Xiao-Dong, Zhang, Xiao-Hui, Xu, Lan-Ping, Zhang, Yuan-Yuan, Sun, Yu-Qian, Jin, Jian, Huang, Xiao-Jun, Wang, Yu

“…Relapse was the major cause of treatment failure in patients with myeloid malignancies after allogeneic hematopoietic stem cell transplantation (allo-HSCT)…”
Get full text

A comparative retrospective study of pre-fibrotic primary myelofibrosis versus overtly fibrotic stage in Qatar: clinicopathological, genetic landscape, risk stratification and survival data (2008–2021) – a single center experience by A. ElKourashy, Sarah, Soliman, Dina, El Omri, Abdelfatteh, Y. Taha, Ruba, Elsabah, Hesham, Alashi, Hind, Chandra, Prem, El Omri, Halima

“…Background In MENA region, there is a lack of evidence on Primary Myelofibrosis (PMF), leading to its underrepresentation in medical literature. This study…”
Get full text

HbA2 :c.96-2A > G mutation: report of 7 cases in China by Yu, Xiao-Hua, Ge, Yi-Yuan, Ma, Xiao-Min, Zeng, Guang-Kuan, Liao, Yu-Wei, Liu, Li-Li, Cao, Yan-Bin, Liang, Jian-Lian, Lai, Bai-Ru, Zeng, Yan-Qing, Huang, Yu-Chan, Yang, Li-Ye

“…To analyze the hematological phenotype and genotype of HbA2: c.96-2A > G carriers.OBJECTIVETo analyze the hematological phenotype and genotype of HbA2: c.96-2A…”
Get full text

Identification and prognostic analysis of metabolic genes associated with TP53 mutation in multiple myeloma by Tang, Xiaoyan, Chen, Yongping

“…TP53 gene mutation is crucial in determining the prognosis of Multiple Myeloma (MM) patients. Understanding metabolic genes linked to TP53 mutation is vital…”
Get full text

Regulation of STAT5 phosphorylation and interaction with SHP1 by lnc-AC004893, a long non-coding RNA overexpressed in myeloproliferative neoplasms by Yang, Junjun, Ruan, Jichen, Zhou, Bin, Ye, Sisi, Gao, Shenmeng, Zheng, Xiaoqun

“…Constitutive activation of Janus kinase 2 (JAK2)/signal transducer and activator of transcription (STAT) signaling pathway is central to the pathogenesis of…”
Get full text

Next generation sequencing reveals the mutation landscape of Chinese MDS patients and the association between mutations and AML transformations by Liu, Yu, Cheng, Huanchen, Cheng, Mei, Sun, Meng, Ma, Jun, Gong, Tiejun

“…Approximately 30% of patients with MDS eventually develop to acute myeloid leukemia (AML). Our study aimed to investigate the mutation landscape of Chinese MDS…”
Get full text

Clinical characteristics of megaloblastic anemia with pancytopenia by Tang, Lin, Miao, Jing, Wang, Jinbi

“…In this study, we aimed to explore the clinical characteristics of patients with megaloblastic anemia and pancytopenia. Data on patient characteristics,…”
Get full text

Efficacy of daratumumab on multiple myeloma patients with renal insufficiency: a systematic review and meta-analysis by Jiang, Hua, Li, Lu, Guo, Meiyu, Li, Meizhang, Wu, Hao, Chen, Xiaomei, Gao, Mingzhao, Xu, Qianqian, Mi, Jia, Cui, Canchan, Fu, Weijun

“…Renal insufficiency (RI) is a key factor affecting the prognosis of multiple myeloma (MM) patients. Because the benefit of daratumumab for treating MM patients…”
Get full text

When Chinese patients with plasma cell disorders encountered the nationwide Omicron outbreak (December 2022): a real-world multicenter and multiregional study by Jiang, Xincheng, Han, Xiaoyan, Jin, Fengyan, An, Gang, Hou, Jian, He, Jingsong, Wang, Qingming, Wu, Wenjun, Zhao, Yi, Jiang, Songfu, Li, Shuchan, Xu, Zhenshu, Zheng, Gaofeng, Yang, Yang, Chen, Qingxiao, He, Donghua, Li, Yi, Cai, Zhen

“…This study aims to assess the impact of the nationwide Omicron outbreak in December 2022 on Chinese patients with plasma cell disorders (PCD), focusing on the…”
Get full text

Presence of triple positive driver mutations in JAK2, CALR and MPL in primary myelofibrosis: a case report and literature review by Zhao, Long, Zhang, Hao, Chen, Juan, Ma, Haizhen, Liu, Bei

“…Primary myelofibrosis (PMF) is the most advanced subtype among the classic Philadelphia chromosomenegative myeloproliferative neoplasms (MPNs). A majority of…”
Get full text

High expression of EBP is an adverse prognostic factor for de novo acute myeloid leukemia by Lian, Jiaying, Zhuang, Haihui, Li, Fenglin, Pei, Renzhi, Chen, Dong, Ye, Peipei, Li, Shuangyue, Wang, Tiantian, Cao, Junjie, Yuan, Jiaojiao, Yu, Zhuruohan, Lu, Ying

“…Acute myeloid leukemia (AML) is a heterogeneous disease, for which identifying reliable prognostic markers is critical for accurate clinical prognosis and…”
Get full text